Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, ...

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.

Vir Biotechnology (NASDAQ:VIR) is set to give its latest quarterly earnings report on Wednesday, 2025-05-07. Here's what investors need to know before the announcement. Analysts estimate that Vir ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Vir Biotechnology, Inc. before investing. In this article, we go over a few key ...

In RIT’s biotechnology bachelor’s degree you’ll develop technologies for genetics, agriculture, pharmaceuticals, vaccine development, energy/ environment, forensics, and more. Hands on Experience: ...

No­ma Ther­a­py, a vir­tu­al ke­t­a­mine-as­sist­ed ther­a­py provider, has launched with $4.25 mil­lion in fund­ing, End­points News learned ex­clu­sive­ly.

Industry pioneers converge to chart a new era where artificial intelligence is redefining health and biotech. HONG KONG, April 29, 2025 /PRNewswire/ -- Dalton Venture CEO Summit 2025 , jointly hosted ...